Glaukos R&D Spending Growth & History (GKOS)
Glaukos's r&d spending was $150.6M for fiscal 2025.
View full Glaukos company overviewGlaukos annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $150.6M | $14.2M | +10.40% |
| 2024 | 2024-12-31 | $136.4M | −$2.3M | −1.69% |
| 2023 | 2023-12-31 | $138.8M | $15.5M | +12.57% |
| 2022 | 2022-12-31 | $123.3M | $22.3M | +22.05% |
| 2021 | 2021-12-31 | $101.0M | $15.6M | +18.28% |
| 2020 | 2020-12-31 | $85.4M | $17.1M | +25.01% |
| 2019 | 2019-12-31 | $68.3M | $18.6M | +37.51% |
| 2018 | 2018-12-31 | $49.7M | $10.8M | +27.69% |
| 2017 | 2017-12-31 | $38.9M | $9.7M | +33.13% |
| 2016 | 2016-12-31 | $29.2M | $4.2M | +16.67% |
| 2015 | 2015-12-31 | $25.0M | $5.8M | +30.42% |
| 2014 | 2014-12-31 | $19.2M | $3.7M | +23.82% |
| 2013 | 2013-12-31 | $15.5M | — | — |
Glaukos quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $51.3M | $14.8M | +40.40% |
| Q1 2026 | 2026-03-31 | $44.1M | $11.8M | +36.45% |
| Q4 2025 | 2025-12-31 | $43.7M | $7.1M | +19.50% |
| Q3 2025 | 2025-09-30 | $38.1M | $3.3M | +9.57% |
| Q2 2025 | 2025-06-30 | $36.5M | $2.1M | +6.13% |
| Q1 2025 | 2025-03-31 | $32.4M | $1.6M | +5.30% |
| Q4 2024 | 2024-12-31 | $36.5M | −$535,000 | −1.44% |
| Q3 2024 | 2024-09-30 | $34.7M | $1.4M | +4.34% |
| Q2 2024 | 2024-06-30 | $34.4M | $1.2M | +3.59% |
| Q1 2024 | 2024-03-31 | $30.7M | −$4.4M | −12.64% |
| Q4 2023 | 2023-12-31 | $37.1M | $1.3M | +3.49% |
| Q3 2023 | 2023-09-30 | $33.3M | $4.4M | +15.35% |
| Q2 2023 | 2023-06-30 | $33.2M | $1.5M | +4.80% |
| Q1 2023 | 2023-03-31 | $35.2M | $8.3M | +30.86% |
| Q4 2022 | 2022-12-31 | $35.8M | $9.1M | +34.24% |
| Q3 2022 | 2022-09-30 | $28.9M | $24,000 | +0.08% |
| Q2 2022 | 2022-06-30 | $31.7M | $7.5M | +30.74% |
| Q1 2022 | 2022-03-31 | $26.9M | $5.7M | +26.66% |
| Q4 2021 | 2021-12-31 | $26.7M | $5.4M | +25.58% |
| Q3 2021 | 2021-09-30 | $28.8M | $8.5M | +42.07% |
| Q2 2021 | 2021-06-30 | $24.3M | $5.3M | +27.86% |
| Q1 2021 | 2021-03-31 | $21.2M | −$3.7M | −14.69% |
| Q4 2020 | 2020-12-31 | $21.2M | $1.2M | +6.06% |
| Q3 2020 | 2020-09-30 | $20.3M | $3.0M | +17.51% |
| Q2 2020 | 2020-06-30 | $19.0M | $1.9M | +11.14% |
| Q1 2020 | 2020-03-31 | $24.9M | $10.9M | +78.56% |
| Q4 2019 | 2019-12-31 | $20.0M | $7.1M | +54.60% |
| Q3 2019 | 2019-09-30 | $17.3M | $4.1M | +30.87% |
| Q2 2019 | 2019-06-30 | $17.1M | $4.5M | +35.35% |
| Q1 2019 | 2019-03-31 | $13.9M | $3.0M | +27.73% |
| Q4 2018 | 2018-12-31 | $13.0M | $2.4M | +23.11% |
| Q3 2018 | 2018-09-30 | $13.2M | $3.4M | +34.65% |
| Q2 2018 | 2018-06-30 | $12.6M | $3.0M | +30.91% |
| Q1 2018 | 2018-03-31 | $10.9M | $2.0M | +21.96% |
| Q4 2017 | 2017-12-31 | $10.5M | $3.1M | +42.25% |
| Q3 2017 | 2017-09-30 | $9.8M | $2.0M | +25.59% |
| Q2 2017 | 2017-06-30 | $9.6M | $2.7M | +38.50% |
| Q1 2017 | 2017-03-31 | $8.9M | $1.9M | +26.62% |
| Q4 2016 | 2016-12-31 | $7.4M | $1.1M | +17.54% |
| Q3 2016 | 2016-09-30 | $7.8M | $1.6M | +26.47% |
| Q2 2016 | 2016-06-30 | $7.0M | −$384,000 | −5.23% |
| Q1 2016 | 2016-03-31 | $7.1M | $1.8M | +34.77% |
| Q4 2015 | 2015-12-31 | $6.3M | $988,000 | +18.62% |
| Q3 2015 | 2015-09-30 | $6.2M | $1.1M | +21.21% |
| Q2 2015 | 2015-06-30 | $7.3M | $2.9M | +65.97% |
| Q1 2015 | 2015-03-31 | $5.2M | $857,000 | +19.55% |
| Q4 2014 | 2014-12-31 | $5.3M | — | — |
| Q3 2014 | 2014-09-30 | $5.1M | — | — |
| Q2 2014 | 2014-06-30 | $4.4M | — | — |
| Q1 2014 | 2014-03-31 | $4.4M | — | — |
Glaukos r&d spending trends
Over the last five fiscal years, Glaukos's r&d spending increased from $85.4M to $150.6M, a change of $65.2M. The latest reported quarter, Q2 2026, shows $51.3M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Glaukos source filings ↗